Jun 21 2025
A new study published in the journal Brain Research provides evidence that chronic use of a lipid-based cannabidiol (CBD) nanoemulsion may help reduce anxiety and panic-like behavior by targeting brain areas involved in emotional regulation. Conducted by researchers from the Universidade Federal do Ceará and Universidade Federal de São Paulo in Brazil, the study evaluated …
Jun 19 2025
A new international study has found that people with endometriosis who use cannabis overwhelmingly view it as more effective and better tolerated than traditional pharmaceuticals, with nearly all participants saying they plan to continue using it to manage their symptoms. Published in the journal Reproduction & Fertility and conducted by researchers from Griffith University and …
Jun 17 2025
A study published in the Journal of Pain and Palliative Care Pharmacotherapy found that full-spectrum cannabis extracts containing both THC and CBD significantly improved symptoms of chronic pain in most patients, while also reducing anxiety and insomnia. The prospective, open-label study followed 88 patients between the ages of 35 and 88 who were diagnosed with …
Jun 17 2025
A new study out of Thailand details a novel process for producing broad-spectrum CBD extracts with minimal Δ9-THC, using optimized ethanolic extraction and centrifugal partition chromatography (CPC). Researchers from Naresuan University and the University of Phayao set out to refine cannabis extraction techniques to yield extracts rich in cannabidiol (CBD) but with negligible psychoactive THC …
Jun 16 2025
A single dose of psilocybin paired with psychotherapy significantly reduced symptoms of depression and anxiety in cancer patients, with many maintaining improvements for two years, according to a new study published in the journal Cancer. The phase 2 trial followed 30 cancer patients diagnosed with major depressive disorder who received a 25 mg dose of …
Jun 16 2025
A new study from Texas A&M University has found that two-thirds of CBD tinctures sold online in the United States are inaccurately labeled. Researchers tested 18 tinctures marketed as either full-spectrum or broad-spectrum CBD and discovered that two-thirds—12 of the 18—had CBD levels that deviated by more than 10% from what was stated on the …
Jun 16 2025
A large majority of chronic pain patients certified to use medical marijuana report using it daily and experiencing strong symptom relief, with few side effects, according to a new study published in Cureus. Researchers from Rothman Orthopaedic Institute, Penn State College of Medicine, and Thomas Jefferson University conducted a prospective study of 129 patients certified …
Jun 16 2025
According to a new study published in the journal Pharmacological Reports, cannabidiol (CBD) provided antidepressant-like effects in adolescent rats, with no apparent long-term consequences on cognition or emotional behavior. For the study, researchers administered CBD at varying doses (10, 30, and 60 mg/kg) to adolescent male and female rats over the course of seven days. …
Jun 16 2025
According to a study published in the journal Translational Psychiatry, psilocybin reduced key symptoms of depression and anxiety in mice subjected to chronic stress. “In the search for novel rapid-acting antidepressants, the psychedelic psilocybin has emerged as a promising therapy in several clinical trials”, states the study’s abstract. “However, its antidepressant mechanism of action is …
Jun 14 2025
A new study published in the Journal of Cannabis Research found that a powdered formulation of THC and CBD more than doubles cannabinoid bioavailability compared to traditional oil-based drops. The study involved 14 healthy adults who received two different oral formulations containing 8 mg of THC and 8 mg of CBD: one as standard oil …
